Keith Speights

1 week ago | nasdaq.com | Keith Speights

Pick a time frame -- year to date, last 12 months, last three years, last five years, or last 10 years. Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the period. This might seem like the kind of stock you'd want to avoid. However, I have a different perspective about Pfizer. Here are three reasons why I just bought more of this beaten-down stock. Where to invest $1,000 right now?

1 week ago | fool.com | Keith Speights

Pick a time frame -- year to date, last 12 months, last three years, last five years, or last 10 years. Regardless of which you choose, Pfizer's (PFE -0.57%) share price has declined during the period. This might seem like the kind of stock you'd want to avoid. However, I have a different perspective about Pfizer. Here are three reasons why I just bought more of this beaten-down stock. 1.

1 week ago | fool.com.au | Keith Speights

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. Warren Buffett readily admits that he doesn't understand artificial intelligence (AI). He has also said that he won't invest in businesses that he understands. So, does that mean the legendary investor doesn't own any AI stocks? Nope. Actually, Buffett has invested roughly $90 billion in nine companies that are heavily focused on AI. Here they are -- and which one is the best of the bunch.

1 week ago | fool.com | Keith Speights |David Jagielski

You're unlikely to have a warm-and-fuzzy feeling after buying some stocks. Instead, some stocks can keep you awake at night because of their high volatility and risk. The good news, though, is that there are plenty of growth stocks you can buy without any hesitation or trepidation. Three Motley Fool contributors believe they've found stocks that fit the bill. Here's why they picked Eli Lilly (LLY 0.82%), Novo Nordisk (NVO -1.39%), and Vertex Pharmaceuticals (VRTX -0.98%).

1 week ago | dailytradealert.com | Keith Speights

I first initiated a position in Enterprise Products Partners (EPD) more than two years ago. How has that investment fared so far? Not bad. The midstream energy company has generated a total return of roughly 45%. Granted, that performance lags behind the S&P 500’s total return of 56% during the same period. However, one thing I could count on, rain or shine, with Enterprise Products Partners was (and is) its juicy distribution. How does the stock look today? Absurdly good, in my opinion.